 "Dr Lal PathLab's Rs 630-cr IPO to open Dec 8")
The Rs 630-crore initial public offering (IPO) of diagnostic chain company Dr Lal PathLab's will open on December 8.
The Delhi-based firm has fixed the price band for its IPO from Rs 540 to Rs 550 per share. At the top end of the price band, the IPO size works out to around Rs 630 crore.
The entire 11.6-million share issue is offer for sale by promoters and existing shareholders. The offering consists of 14.04 per cent of the paid up capital of the company and will give the company a valuation of around Rs 4,500 crore.
Dr Lal would be offering an additional discount of Rs 15 to retail investors, those investing up to Rs 2 lakh.
Kotak Mahindra Capital and Citigroup Global Markets are the investment banks handling the IPO.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app